Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3289112 | 0.92 | HTT (0.70) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL16882316 | 0.89 | SMN1; SMN2 (0.73) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL13003556 | 0.89 | HTT (0.77) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL15020751 | 0.88 | HTT (0.64) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL3358984 | 0.88 | HTT (0.75) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL30669320 | 0.88 | HTT (0.75) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL8106191 | 0.87 | HTT (0.70) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL3357703 | 0.86 | HTT (0.73) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL28377462 | 0.86 | HTT (0.54) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL20382948 | 0.86 | HTT (0.68) | HTTSMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053929-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | CHELATION PARTNERS INCORPORATED (CA) | 2026-02-26 | — | — | US | disclosed |
| CN-115260162-B | 3-Hydroxy-4-pyridone-ciprofloxacin coupling, preparation method and application thereof | 浙江大学 | 2024-07-05 | — | — | CN | disclosed |
| US-12024490-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms for therapeutic use in treating diseases in animals, fish or humans | CHELATION PARTNERS INCORPORATED (CA) | 2024-07-02 | — | — | US | disclosed |
| CN-117338950-A | Polymer material for reducing cardiac toxicity of anthracycline chemotherapeutics and application thereof | 天津大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-116425718-A | Derivatives of phthalimido-3-hydroxypyridine-4-one and application thereof | 浙江工业大学 | 2023-07-14 | — | — | CN | disclosed |
| WO-2023070780-A1 | MONOAMINE OXIDASE B INHIBITOR HAVING POTENTIAL IRON CHELATING ACTIVITY AND USE THEREOF | 浙江工业大学 | 2023-05-04 | — | — | WO | disclosed |
| CN-115260162-A | 3-hydroxy-4-pyridone-ciprofloxacin coupling compound and preparation method and application thereof | 浙江大学 | 2022-11-01 | — | — | CN | disclosed |
| CN-114149417-A | Monoamine oxidase B inhibitor with potential iron chelation activity and application thereof | 浙江工业大学 | 2022-03-08 | — | — | CN | disclosed |
| US-20220002250-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS FOR THERAPEUTIC USE IN TREATING DISEASES IN ANIMALS, FISH OR HUMANS | JUBILANT CHEMSYS LTD. (IN) | 2022-01-06 | — | — | US | disclosed |
| US-20220002250-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS FOR THERAPEUTIC USE IN TREATING DISEASES IN ANIMALS, FISH OR HUMANS | JUBILANT CHEMSYS LTD. (IN) | 2022-01-06 | — | — | US | disclosed |
| EP-3504188-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | Chelation Partners Incorporated (CA) | 2019-07-03 | — | — | EP | disclosed |
| US-20190169126-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | CHELATION PARTNERS INCORPORATED (CA) | 2019-06-06 | — | — | US | disclosed |
| US-20190169126-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | CHELATION PARTNERS INCORPORATED (CA) | 2019-06-06 | — | — | US | disclosed |
| WO-2018035613-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | CHELATION PARTNERS INCORPORATED (CA) | 2018-03-01 | — | — | WO | disclosed |
| US-20160038604-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | CHELATION PARTNERS INCORPORATED | 2016-02-11 | — | — | US | disclosed |
| US-20160038604-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | CHELATION PARTNERS INCORPORATED | 2016-02-11 | — | — | US | disclosed |
| EP-2717886-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | Chelation Partners Incorporated (CA) | 2014-04-16 | — | — | EP | disclosed |
| WO-2012167368-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | CHELATION PARTNERS INCORPORATED (CA) | 2012-12-13 | — | — | WO | disclosed |
| EP-1006112-A1 | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers | Cerebrus Pharmaceuticals Limited (GB) | 2000-06-07 | — | — | EP | disclosed |
| EP-1006108-A1 | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers | Cerebrus Pharmaceuticals Limited (GB) | 2000-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002250-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS FOR THERAPEUTIC USE IN TREATING DISEASES IN ANIMALS, FISH OR HUMANS | TFRC, HMBS, PICALM | HTT 1484/4885SMN1; SMN2 812/4885MEN1 2264/4885 |
| US-12024490-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms for therapeutic use in treating diseases in animals, fish or humans | TFRC, HMBS, PICALM | HTT 1484/4885SMN1; SMN2 812/4885MEN1 2264/4885 |
| US-20190169126-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | PICALM, HMBS, TFRC | HTT 3362/4885SMN1; SMN2 2683/4885MEN1 1739/4885 |
| US-20260053929-A1 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | HAMP, SLC40A1, TFRC | HTT 3080/4885SMN1; SMN2 1929/4885MEN1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.